Lipotocin drug with the main ingredient is Thioctic acid 300 mg, which is commonly used in the treatment of sensory disorders caused by polyneuropathy
10 Although, the efficiency of immunosuppressive treatment in different type of polyneuropathy has been controversial, treatment with corticosteroids (
FDA approves new drug for treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for this rare, debilitating and
Venlafaxine relieves pain in polyneuropathy and may be as effective as imipramine. Tricyclic antidepressants (TCA) are first-line drugs for the treatment of
10 Although, the efficiency of immunosuppressive treatment in different type of polyneuropathy has been controversial, treatment with corticosteroids (
FDA approves new drug for treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for this rare, debilitating and
Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). First and only subcutaneous immunoglobulin (SCIg) approved
Diabetes mellitus stands as the predominant cause behind small-fiber polyneuropathy. Thus, hydroxyzine is considered as first drug of choice in treatment of
It is indicated for the treatment of following diseases: Polyneuropathy of Use in children: There is no information on the use of this drug in children.
Comments
4*